Notable Analyst Rating Changes 8/25: BBT, CSUN, LEG, BMS Upgraded; CVC, ALO, HW Downgraded
More News related to ALO
- Does CV Therapeutics (CVTX) Have A Case of Merger-Cockiness?
- Top 15 For 2008 (No. 14): M&A Wreckage
- King Pharmaceuticals (KG) Completes Acquisition of Alpharma
- S&P Announces Changes to US Indices: IRM for UST, FSP for ALO
- Notable Analyst Rating Changes 12/03: LMT, DRI, CTAS Upgraded; ALO, SYK, FSLR Downgraded
More News related to BBT
- Piedmont Natural Gas CEO named BB&T director
- BB&T (BBT) to Incur $48M Charge in Q2 Related to TARP Repayment
- Deutsche Bank Says CMA, HBAN, KEY, RF and ZION Best Positioned For Increase In Interest Rates
- BB&T Second Quarter 2009 Earnings Conference Call
- Top 10 News Items 6/15-6/19: Obama Unveils Sweeping Regulatory Reform; S&P Cuts Ratings on 22 US Banks; RIM Earnings Inline, But Guidance Soft
More News related to BIOD
- Biodel Inc. to Present at 8th Annual Needham & Company Life Sciences Conference on June 11th, 2009
- VIAject(R) Presentations at ADA Meeting Highlight Drug's Mechanism of Absorption and Microvascular Effects
- Biodel Inc. Reports Second Quarter Fiscal Year 2009 Financial Results
- Unusual 11 Mid-Day Movers 3/25: CBG, MIC, JBL, HW Higher; DRYS, AIG, AMN, FTBK Lower
- Morning Movers 3/25: CBG, BIOD, ACAS, BBI, AMD Higher; DRYS, SOLF, STZ, CYPB, DSW Lower
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Citi upgrades BB&T (NYSE: BBT) from Hold to Buy. Price target $34.
Jefferies & Co upgrades China Sunergy (Nasdaq: CSUN) from Hold to Buy. Price target $15.
Stifel Nicolaus upgrades Leggett & Platt (NYSE: LEG) from Hold to Buy.
Merrill Lynch upgrades Bemis (NYSE: BMS) from Underperform to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades Cablevision Systems (NYSE: CVC) from Buy to Sell. Price target $29.
Roth Capital downgrades Alpharma, Inc. (NYSE: ALO) from Buy to Hold with a $36 price target.
Wedbush Morgan downgrades Headwaters Inc. (NYSE: HW) from Buy to Hold with a $15 price target.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Merrill Lynch initiates coverage on HCP (NYSE: HCP) with a Neutral. Price target $35.
Leerink Swann initiates coverage on Biodel Inc. (Nasdaq: BIOD) with an Outperform rating.
RBC Capital initiates coverage on EXCO Resources Inc. (NYSE: XCO) with an Outperform rating and $43 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.00
-0.31Related Entities
- Stifel Nicolaus
- Citi
- Jefferies & Co
- Merrill Lynch
- Roth Capital
- RBC Capital
- Wedbush Morgan
- BB&T Capital Markets
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
